Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report

Breast cancer is the most common malignancy among women in the United States with the second highest incidence of cancer-related death following lung cancer. The decision-making process regarding adjuvant therapy is a time intensive dialogue between the patient and her oncologist. There are multiple...

Full description

Bibliographic Details
Main Authors: Steven R. Schuster, Barbara A. Pockaj, Mary R. Bothe, Paru S. David, Donald W. Northfelt
Format: Article
Language:English
Published: MDPI AG 2012-09-01
Series:Journal of Personalized Medicine
Subjects:
breast cancer
genomic profiling
medical decision-making
Oncotype DX
chemotherapy
personalized medicine
Online Access:http://www.mdpi.com/2075-4426/2/3/71

Internet

http://www.mdpi.com/2075-4426/2/3/71

Similar Items